Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
ASNI Calgary 2015
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Episode 24 with Professor Aksel Siva discussing asymptomatic MS
Episode 33 with Dr. Pierre-Antoine Gourraud on the role of human leukocyte antigen in MS
Optical Coherence Tomography in Multiple Sclerosis.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Neuroscience: Improving Translation of Animal Models for Nervous System Disorders: A Workshop
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.
JC polyomavirus mutants escape antibody-mediated neutralization.
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.

Pages